and Digital-to-Analog Converter (DAC) IP cores. These advanced solutions set a new benchmark for performance and efficiency, catering to diverse industries such as automotive, industrial automation, ...

The AFE includes two 12-bit, 4GSPS I/Q ADC pairs, two 14-bit, 8GSPS I/Q DAC pairs, four ... Unleash the power of precision and innovation with the NS_TRX_12G_T16, a state-of-the-art 12-bit, 12-Gsps ...

And then some of them make it here. A DAC, or digital-to-analog converter, is crucial for transforming digital audio files into the analog sound we actually hear. While every digital music source ...

The AD5593R is an IO device with 8 channels that can be configured as ADC DAC or GPIO. In that sense it is one of the most flexible IO expanders on the market. The device is NOT tested with hardware ...

-- Initiated dosing in Phase 1 clinical trial cohort evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in patients with advanced gastric/gastroesophageal junction ...

Specs-wise, this little all-aluminum, baby blue and silver gadget — which also comes in a much more serious Midnight Black color — covers everything you could want in a headphone DAC ...

The latest round of federal CHIPS Act awards includes $105 million for Analog Devices to upgrade its factories in the suburbs around Portland and Boston, the Commerce Department announced early ...

MRG007 is an antibody drug conjugate (ADC), a type of therapy made by linking a toxic drug payload to a targeting antibody. Lepu has not disclosed the target of the drug, nor has ArriVent.

In this article, we are going to take a look at where Agree Realty Corporation (NYSE:ADC) stands against the other monthly dividend stocks. Despite common perceptions, 2024 turned out to be a ...

Written by Maria-Cristina Florian Published on January 14, 2025 The exhibition showcases a diverse range of solutions from Denmark and internationally demonstrating how urban design and planning ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...